SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Ella Fitzgerald — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElla Fitzgerald
Date of birth1917-04-25
IdentifiersMRN HR-ML029-SYN-TD; SSN (made up) 000-29-3640
Document date1987-05-11
AuthorOdessa Whitlow, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for new patient visit: diabetes with calf pain on walking, low glucose after late shows, eye and foot examinations, and cardiovascular risk. [S]

Objective

Hemoglobin A1c: 8.6% (high); Sodium: 139 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.92 mg/dL; eGFR: 67 mL/min/1.73 m²; Glucose: 168 mg/dL (high); Urine albumin-creatinine ratio: 18 mg/g; Total cholesterol: 164 mg/dL; LDL cholesterol: 92 mg/dL; HDL cholesterol: 44 mg/dL (low); Triglycerides: 140 mg/dL; ALT: 22 U/L; AST: 24 U/L; Hemoglobin: 12.4 g/dL; Vitamin B12: 386 pg/mL; Ankle-brachial index, right: 0.62 (low); Ankle-brachial index, left: 0.74 (low); Toe-brachial index, right: 0.46 (low); Toe-brachial index, left: 0.55 (low); Best-corrected visual acuity, right eye (ETDRS letters): 64 (low); Best-corrected visual acuity, left eye (ETDRS letters): 81. [S]

Change since baseline:

Vital Signs

DateMeasureValueUnitProvenance
1987-05-11Body height165cmS
1987-05-11Body weight84kgS
1987-05-11Body mass index (BMI) [Ratio]30.9kg/m2S
1987-05-11Systolic blood pressure126mm[Hg]S
1987-05-11Diastolic blood pressure70mm[Hg]S
1987-05-11Heart rate62/minS
1987-05-11Respiratory rate16/minS
1987-05-11Body temperature36.6CelS
1987-05-11Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1987-05-11Hemoglobin A1c/Hemoglobin.total in Blood8.6%Below 5.7% is normal; her individualized goal is below 7.5%HighS
1987-05-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1987-05-11Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
1987-05-11Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
1987-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1982)/1.73 sq M67mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1987-05-11Glucose [Mass/volume] in Serum or Plasma168mg/dL70-99 mg/dLHighS
1987-05-11Albumin/Creatinine [Mass Ratio] in Urine18mg/g<=30 mg/gNormalS
1987-05-11Cholesterol [Mass/volume] in Serum or Plasma164mg/dL<=199 mg/dLNormalS
1987-05-11Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation92mg/dLHer goal with coronary and peripheral artery disease is below 55 mg/dLNormalS
1987-05-11Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=50 mg/dLLowS
1987-05-11Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
1987-05-11Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-35 U/LNormalS
1987-05-11Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L10-35 U/LNormalS
1987-05-11Hemoglobin [Mass/volume] in Blood12.4g/dL11.6-15 g/dLNormalS
1987-05-11Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma386pg/mL232-1245 pg/mLNormalS
1987-05-11Ankle-brachial index0.62{ratio}1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormalLowS
1987-05-11Ankle-brachial index0.74{ratio}1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormalLowS
1987-05-11Toe brachial index - right0.46{ratio}Above 0.70 normalLowS
1987-05-11Toe brachial index - left0.55{ratio}Above 0.70 normalLowS
1987-05-11Visual acuity best corrected Right eye by ETDRS eye chart64{letters}85 letters is about 20/20; 80 about 20/25; 65 about 20/50LowS
1987-05-11Visual acuity best corrected Left eye by ETDRS eye chart81{letters}85 letters is about 20/20; 80 about 20/25; 65 about 20/50NormalS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with breakfast and the evening mealOral route1977-03-01activeS
Glipizide 10 mg oral tablet, one tablet by mouth twice daily before mealsOne tablet by mouth twice daily before breakfast and the evening mealOral route1982-09-01 to 1987-05-11completedS
Insulin glargine 100 units/mL pen, 30 units under the skin at bedtime30 units at bedtimeSubcutaneous route1984-04-01 to 1987-05-11completedS
Insulin glargine 100 units/mL pen, 24 units under the skin each morning24 units each morning, at the same clock time on tour, with written time-zone adjustmentsSubcutaneous route1987-05-11activeS
Atorvastatin 40 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1986-06-02 to 1987-05-11completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1987-05-11activeS
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1986-06-02activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1986-06-02activeS
Empagliflozin 10 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning; hold on days she cannot eat or drink normally and before surgeryOral route1987-05-11activeS
Glucagon 3 mg nasal powder, one spray into one nostril for a severe low glucoseOne spray into one nostril if she cannot safely swallow during a low glucose; may repeat once after 15 minutes with a new device; call 911Nasal route1987-05-11activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes mellitus with peripheral artery disease: cramping in both calves after about one and a half blocks of walking, worse on the right, easing within minutes of rest; no rest pain, wounds, or color change. Resting ankle-brachial index 0.62 right and 0.74 left, toe-brachial index 0.46 and 0.55; dorsalis pedis and posterior tibial pulses absent on the right and faint on the left. A1c 8.6% on metformin, glipizide and glargine, with low glucose readings (to 52 mg/dL) after late performances. Foot: protective sensation intact to the 10-g monofilament at all sites and to vibration; callus under the second metatarsal heads; hammer toes of the second and third toes; no ulcer (IWGDF risk category 2). Synthetic modern episode linked to her documented diabetes and its circulatory complicationsactiveconfirmed E11.51S — Synthetic modern diagnosis; the type of diabetes was not made public and is synthetic.
Moderate nonproliferative diabetic retinopathy with center-involving diabetic macular edema in the right eye (best-corrected acuity 64 letters, about 20/50) and moderate nonproliferative retinopathy without macular edema in the left eye (81 letters); lens implants in both eyes from earlier cataract surgery. Synthetic modern episode linked to her documented diabetic eye problemsactiveconfirmed E11.3311S — Synthetic modern eye diagnosis on retinal imaging and optical coherence tomography in the clinic; the left eye is described in the display.
Coronary artery disease after five-vessel coronary bypass surgery last year, with an intensive care stay; no angina now; on aspirin, a statin, and metoprolol. Synthetic modern episode linked to her documented heart surgeryactiveconfirmed I25.10S — Synthetic modern coding of her documented heart surgery; bypass grafts are described in the display.

Assessment

Plan of Treatment